Booz Allen Hamilton Holding Corporation (BAH), the McLean, Virginia-based technology and consulting firm, has become a focal point for investors debating whether it can reclaim the psychologically significant $100 mark. After peaking near $110 in the past year, the stock has pulled back sharply, leaving $100 as a natural round-number objective that sits above the current price but below its recent highs. Because the company traded comfortably above $100 within the last 12 months, the question is less about whether the level is possible and more about what conditions would be required to get back there.
BAH trades near $75.65, giving it a market capitalization of roughly $9.1 billion. The stock carries a price-to-earnings (P/E) ratio of about 12 times trailing earnings and offers a dividend yield above 3%, reflecting its status as a mature, cash-generative government services provider rather than a high-growth technology name. Revenue over the trailing twelve months is approximately $11.1 billion, with net income near $772 million.
The company's strongest argument centers on its $39.5 billion total backlog, a multiyear pipeline of work that provides substantial revenue visibility. Booz Allen's defense and intelligence segment has remained comparatively resilient, and the firm is actively expanding into higher-margin product offerings. In June 2026 it agreed to acquire Ultra Mission Solutions in a $720 million transaction, part of a broader push into defense technology, or "DefTech," products that analysts expect to deliver stronger growth and margins than traditional consulting.
The company's deep positioning in artificial intelligence and cybersecurity for the U.S. federal government also supports the longer-term story. As agencies prioritize AI adoption, data modernization, and digital defense, Booz Allen's cleared workforce and technical capabilities position it to capture a meaningful share of those budgets. Notably, its most recent quarter delivered adjusted earnings per share well above Wall Street estimates, underscoring disciplined cost management even as revenue softened.
The most immediate obstacle is the company's civilian-government, or "FedCiv," business, which has weakened as high-margin programs wound down. Revenue fell about 4% year over year in the latest quarter, and net income declined roughly 27%, prompting management to issue cautious guidance for the current fiscal year. A slowing growth trajectory has weighed on sentiment and compressed the stock's valuation multiple.
Broader budget uncertainty and shifting federal spending priorities remain persistent risks for a company that derives the vast majority of its revenue from government contracts. Any prolonged government-funding disruption or reprioritization away from the firm's core programs could further delay a return toward triple-digit prices.
Wall Street's view on BAH is unusually divided. The consensus 12-month analyst price target sits around $84 to $85, implying only modest upside from current levels, and several firms — including Goldman Sachs and Bank of America — hold Sell or Underperform ratings with targets as low as $65. On the other end of the spectrum, Cantor Fitzgerald maintains a $140 target and Stifel a $110 target, both citing discounted valuation, free cash flow, and the firm's defense capabilities. This spread, from $65 to $140, reflects genuine disagreement over whether the company can reignite growth. Notably, the average target remains below $100, meaning the $100 level is not yet the consensus expectation — it would require BAH to outperform the Street's current base case.
From a technical standpoint, $100 represents both a psychological round number and a prior area of trading activity from when the stock was higher. The shares currently sit near their 200-day moving average of roughly $76, a zone that has acted as a pivot in recent months. A sustained move above that level would be a first step toward closing the gap to the low-to-mid $80s, which aligns with the consensus analyst target and would serve as an important resistance area. Clearing that zone would then put $100 within view, but the stock would need to rebuild a higher-low, higher-high structure that it has not demonstrated during the recent downtrend.
Traders tracking whether BAH can build momentum toward a higher target may benefit from automated tools that monitor shifting conditions. Tickeron's AI Daily Buy/Sell Signals uses artificial intelligence to continuously scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. These signals can help traders identify emerging opportunities, monitor existing positions, and spot shifting market trends more efficiently. For those following Booz Allen Hamilton's progress, the tool offers a data-driven way to track when the stock's technical profile begins to improve or deteriorate.
A move to $100 for Booz Allen Hamilton is plausible but not assured. The stock's record backlog, defense and intelligence strength, and expanding AI and cybersecurity franchise give it a credible foundation, and its compressed valuation leaves room for a re-rating if sentiment improves. However, the current path is not pointing decisively higher: civilian-market weakness, declining revenue, and a cautious consensus target below $100 all argue for patience. For the level to become realistic, investors would likely need to see a stabilization and reacceleration in growth, particularly in the higher-margin defense technology business, alongside a broader improvement in government-services spending. Until those signals emerge, $100 remains an achievable but demanding objective rather than an imminent one.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, BAH has been loosely correlated with EXPO. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BAH jumps, then EXPO could also see price increases.
| Ticker / NAME | Correlation To BAH | 1D Price Change % | ||
|---|---|---|---|---|
| BAH | 100% | +0.29% | ||
| EXPO - BAH | 50% Loosely correlated | -0.18% | ||
| FCN - BAH | 40% Loosely correlated | -1.49% | ||
| MMS - BAH | 39% Loosely correlated | +0.69% | ||
| EFX - BAH | 35% Loosely correlated | +0.57% | ||
| CPRT - BAH | 33% Loosely correlated | -2.60% | ||
More | ||||
| Ticker / NAME | Correlation To BAH | 1D Price Change % |
|---|---|---|
| BAH | 100% | +0.29% |
| Data Processing Services industry (24 stocks) | 20% Poorly correlated | +0.27% |
| Technology Services industry (397 stocks) | -0% Poorly correlated | +0.87% |